IceCure Medical Ltd (NASDAQ:ICCM – Get Free Report) was the target of a large increase in short interest in July. As of July 15th, there was short interest totalling 196,500 shares, an increase of 26.9% from the June 30th total of 154,900 shares. Currently, 0.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 264,000 shares, the days-to-cover ratio is currently 0.7 days.
Analyst Upgrades and Downgrades
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $3.00 price target on shares of IceCure Medical in a research note on Tuesday, July 2nd.
View Our Latest Report on IceCure Medical
IceCure Medical Trading Up 0.1 %
IceCure Medical (NASDAQ:ICCM – Get Free Report) last posted its quarterly earnings data on Tuesday, May 28th. The company reported ($0.08) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.08). IceCure Medical had a negative return on equity of 101.66% and a negative net margin of 444.30%. The business had revenue of $0.74 million during the quarter, compared to the consensus estimate of $0.80 million. During the same period last year, the company earned ($0.08) earnings per share. Equities analysts predict that IceCure Medical will post -0.28 earnings per share for the current year.
IceCure Medical Company Profile
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Read More
- Five stocks we like better than IceCure Medical
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- This Semiconductor Stock Is ON Track for a New High
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Why SoFi Stock is an Unmissable Growth Opportunity
- Are Penny Stocks a Good Fit for Your Portfolio?
- Has Micron’s Stock Drop Turned Into A Screaming Buy?
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.